Beranda › Penyakit Paru › Utah
Uji klinis Penyakit Paru di Utah
7 studi untuk Penyakit Paru mencari peserta di lokasi di Utah.
Kota di Utah
Teks studi resmi (Bahasa Inggris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Salt Lake City
- Research Site, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450A Study of COVID-19 Vaccine(s) in Children and Adults
- J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
- J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Alpine Research Organization, Clinton
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06572384A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT07730450Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT05297734A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Intermountain Health, Salt Lake City
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT06619561Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.